Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brandy J. Russell is active.

Publication


Featured researches published by Brandy J. Russell.


Journal of Clinical Microbiology | 2005

Serotype-Specific Detection of Dengue Viruses in a Fourplex Real-Time Reverse Transcriptase PCR Assay

Barbara W. Johnson; Brandy J. Russell; Robert S. Lanciotti

ABSTRACT The dengue (DEN) viruses are positive-strand RNA viruses in the genus Flavivirus. Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are important human arboviral diseases caused by infection with one of four closely related but serologically distinct DEN viruses, designated DEN-1, DEN-2, DEN-3, and DEN-4 viruses. All four DEN serotypes are currently cocirculating throughout the subtropics and tropics, and genotypic variation occurs among isolates within a serotype. A real-time quantitative nucleic acid amplification assay has been developed to detect viral RNA of a single DEN virus serotype. Each primer-probe set is DEN serotype specific, yet detects all genotypes in a panel of 7 to 10 representative isolates of a serotype. In single reactions and in fourplex reactions (containing four primer-probe sets in a single reaction mixture), standard dilutions of virus equivalent to 0.002 PFU of DEN-2, DEN-3, and DEN-4 viruses were detected; the limit of detection of DEN-1 virus was 0.5 equivalent PFU. Singleplex and fourplex reactions were evaluated in a panel of 40 viremic serum specimens with 10 specimens per serotype, containing 0.002 to 6,000 equivalent PFU/reaction (0.4 to 1.2 × 106 PFU/ml). Viral RNA was detected in all viremic serum specimens in singleplex and fourplex reactions. Thus, this serotype-specific, fourplex real-time reverse transcriptase PCR nucleic acid detection assay can be used as a method for differential diagnosis of a specific DEN serotype in viremic dengue patients and as a tool for rapid identification and serotyping of DEN virus isolates.


Emerging Infectious Diseases | 2016

Prognostic Indicators for Ebola Patient Survival

Samuel J. Crowe; Matthew J. Maenner; Solomon Kuah; Bobbie R. Erickson; Megan Coffee; Barbara Knust; John D. Klena; Joyce Foday; Darren Hertz; Veerle Hermans; Jay Achar; Grazia Caleo; Michel Van Herp; César G. Albariño; Brian R. Amman; Alison J. Basile; Scott W. Bearden; Jessica A. Belser; Éric Bergeron; Dianna M. Blau; Aaron C. Brault; Shelley Campbell; Mike Flint; Aridth Gibbons; Christin H. Goodman; Laura K. McMullan; Christopher D. Paddock; Brandy J. Russell; Johanna S. Salzer; Angela J. Sanchez

Odds of survival were greatest when first Ebola virus–positive blood sample collected had low viral load.


PLOS ONE | 2013

The Genome Sequence of Lone Star Virus, a Highly Divergent Bunyavirus Found in the Amblyomma americanum Tick

Andrea Swei; Brandy J. Russell; Samia N. Naccache; Beniwende Kabre; Narayanan Veeraraghavan; Mark A. Pilgard; Barbara J. B. Johnson; Charles Y. Chiu

Viruses in the family Bunyaviridae infect a wide range of plant, insect, and animal hosts. Tick-borne bunyaviruses in the Phlebovirus genus, including Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) in China, Heartland virus (HRTV) in the United States, and Bhanja virus in Eurasia and Africa have been associated with acute febrile illness in humans. Here we sought to characterize the growth characteristics and genome of Lone Star virus (LSV), an unclassified bunyavirus originally isolated from the lone star tick Amblyomma americanum. LSV was able to infect both human (HeLa) and monkey (Vero) cells. Cytopathic effects were seen within 72 h in both cell lines; vacuolization was observed in infected Vero, but not HeLa, cells. Viral culture supernatants were examined by unbiased deep sequencing and analysis using an in-house developed rapid computational pipeline for viral discovery, which definitively identified LSV as a phlebovirus. De novo assembly of the full genome revealed that LSV is highly divergent, sharing <61% overall amino acid identity with any other bunyavirus. Despite this sequence diversity, LSV was found by phylogenetic analysis to be part of a well-supported clade that includes members of the Bhanja group viruses, which are most closely related to SFSTV/HRTV. The genome sequencing of LSV is a critical first step in developing diagnostic tools to determine the risk of arbovirus transmission by A. americanum, a tick of growing importance given its expanding geographic range and competence as a disease vector. This study also underscores the power of deep sequencing analysis in rapidly identifying and sequencing the genomes of viruses of potential clinical and public health significance.


The Journal of Infectious Diseases | 2015

Ebola Virus Diagnostics: The US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015

Mike Flint; Christin H. Goodman; Scott W. Bearden; Dianna M. Blau; Brian R. Amman; Alison J. Basile; Jessica A. Belser; Eric Bergeron; Michael D. Bowen; Aaron C. Brault; Shelley Campbell; Ayan K. Chakrabarti; Kimberly A. Dodd; Bobbie R. Erickson; Molly M. Freeman; Aridth Gibbons; Lisa Wiggleton Guerrero; John D. Klena; R. Ryan Lash; Michael K. Lo; Laura K. McMullan; Gbetuwa Momoh; James L. Massally; Augustine Goba; Christopher D. Paddock; Rachael A. Priestley; Meredith Pyle; Mark Rayfield; Brandy J. Russell; Johanna S. Salzer

In August 2014, the Viral Special Pathogens Branch of the US Centers for Disease Control and Prevention established a field laboratory in Sierra Leone in response to the ongoing Ebola virus outbreak. Through March 2015, this laboratory tested >12 000 specimens from throughout Sierra Leone. We describe the organization and procedures of the laboratory located in Bo, Sierra Leone.


American Journal of Tropical Medicine and Hygiene | 2009

Evaluation of IgM Antibody Capture Enzyme-Linked Immunosorbent Assay Kits for Detection of IgM against Japanese Encephalitis Virus in Cerebrospinal Fluid Samples

Vasanthapuram Ravi; Jaimie S. Robinson; Brandy J. Russell; Anita Desai; Nalini Ramamurty; David Featherstone; Barbara W. Johnson

Infection with Japanese encephalitis virus (JEV) is a major public health problem in Asia. Detection of JEV-specific IgM in serum and cerebrospinal fluid (CSF) by the IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) is currently the most widely used diagnostic method to detect JEV infection. Because of the possible presence of IgM cross-reactivity with other flaviviruses in serum and the high ratio of inapparent-to-apparent JEV infections, a positive result in serum only suggests a recent infection and not necessarily an encephalitic illness caused by JEV. Consequently, detection of JEV-specific IgM in CSF assumes great diagnostic relevance. We evaluated two commercial JEV MAC-ELISA kits using 60 CSF samples obtained from patients with acute encephalitis syndrome. The Panbio and XCyton kits had sensitivities of 65-80% and 95% and specificities of 90% and 97.5%, respectively. Performance information on these commercial JEV MAC-ELISA kits for CSF should assist in laboratory-based JE surveillance programs.


PLOS Neglected Tropical Diseases | 2014

Molecular Characterization of Human Pathogenic Bunyaviruses of the Nyando and Bwamba/Pongola Virus Groups Leads to the Genetic Identification of Mojuí dos Campos and Kaeng Khoi Virus

Allison Groseth; Veena Mampilli; Carla Weisend; Eric Dahlstrom; Stephen F. Porcella; Brandy J. Russell; Robert B. Tesh; Hideki Ebihara

Background Human infection with Bwamba virus (BWAV) and the closely related Pongola virus (PGAV), as well as Nyando virus (NDV), are important causes of febrile illness in Africa. However, despite seroprevalence studies that indicate high rates of infection in many countries, these viruses remain relatively unknown and unstudied. In addition, a number of unclassified bunyaviruses have been isolated over the years often with uncertain relationships to human disease. Methodology/Principal Findings In order to better understand the genetic and evolutionary relationships among orthobunyaviruses associated with human disease, we have sequenced the complete genomes for all 3 segments of multiple strains of BWAV (n = 2), PGAV (n = 2) and NDV (n = 4), as well as the previously unclassified Mojuí dos Campos (MDCV) and Kaeng Khoi viruses (KKV). Based on phylogenetic analysis, we show that these viruses populate 2 distinct branches, one made up of BWAV and PGAV and the other composed of NDV, MDCV and KKV. Interestingly, the NDV strains analyzed form two distinct clades which differed by >10% on the amino acid level across all protein products. In addition, the assignment of two bat-associated bunyaviruses into the NDV group, which is clearly associated with mosquito-borne infection, led us to analyze the ability of these different viruses to grow in bat (RE05 and Tb 1 Lu) and mosquito (C6/36) cell lines, and indeed all the viruses tested were capable of efficient growth in these cell types. Conclusions/Significance On the basis of our analyses, it is proposed to reclassify the NDV strains ERET147 and YM176-66 as a new virus species. Further, our analysis definitively identifies the previously unclassified bunyaviruses MDCV and KKV as distinct species within the NDV group and suggests that these viruses may have a broader host range than is currently appreciated.


Journal of Virological Methods | 2014

Development of an algorithm for production of inactivated arbovirus antigens in cell culture

Christin H. Goodman; Brandy J. Russell; Jason O. Velez; Janeen Laven; W.L Nicholson; D.A. Bagarozzi; J.L. Moon; K. Bedi; Barbara W. Johnson

Arboviruses are medically important pathogens that cause human disease ranging from a mild fever to encephalitis. Laboratory diagnosis is essential to differentiate arbovirus infections from other pathogens with similar clinical manifestations. The Arboviral Diseases Branch (ADB) reference laboratory at the CDC Division of Vector-Borne Diseases (DVBD) produces reference antigens used in serological assays such as the virus-specific immunoglobulin M antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA). Antigen production in cell culture has largely replaced the use of suckling mice; however, the methods are not directly transferable. The development of a cell culture antigen production algorithm for nine arboviruses from the three main arbovirus families, Flaviviridae, Togaviridae, and Bunyaviridae, is described here. Virus cell culture growth and harvest conditions were optimized, inactivation methods were evaluated, and concentration procedures were compared for each virus. Antigen performance was evaluated by the MAC-ELISA at each step of the procedure. The antigen production algorithm is a framework for standardization of methodology and quality control; however, a single antigen production protocol was not applicable to all arboviruses and needed to be optimized for each virus.


Journal of Virological Methods | 2008

Microcarrier culture of COS-1 cells producing Japanese encephalitis and dengue virus serotype 4 recombinant virus-like particles

Jason O. Velez; Brandy J. Russell; Holly R. Hughes; Gwong-Jen J. Chang; Barbara W. Johnson

Two stably transfected COS-1 cell lines that secrete recombinant Japanese encephalitis and dengue virus serotype 4 virus-like particles (VLPs) have been adapted to grow on Cytodex 3 microcarriers in an orbital shaker flask platform. The VLPs are used as antigens in diagnostic enzyme-linked immunosorbent assays to detect anti-arboviral IgM and IgG antibodies in human serum samples. Converting from a stationary flask batch system to a microcarrier fed-batch system has led to increases in antigen concentration while decreasing costs by reducing the amount of cell culture medium, disposables, and labor. The cell culture longevity was increased by 48 days in this optimized system, which may be due to a continual supply of nutrients resulting in prolonged survival of the cells on the microcarrier surface. An initial trial using a serum-free medium with this cell line was promising and may lead to reductions in cost, while reducing the variability between batches introduced by fetal bovine serum.


Emerging Infectious Diseases | 2017

Maguari Virus Associated with Human Disease

Allison Groseth; Veronica Vine; Carla Weisend; Carolina Guevara; Douglas M. Watts; Brandy J. Russell; Robert B. Tesh; Hideki Ebihara

Despite the lack of evidence for symptomatic human infection with Maguari virus (MAGV), its close relation to Cache Valley virus (CVV), which does infect humans, remains a concern. We sequenced the complete genome of a MAGV-like isolate (OBS6657) obtained from a febrile patient in Pucallpa, Ucayali, Peru, in 1998. To facilitate its classification, we generated additional full-length sequences for the MAGV prototype strain, 3 additional MAGV-like isolates, and the closely related CVV (7 strains), Tlacotalpan (1 strain), Playas (3 strains), and Fort Sherman (1 strain) viruses. The OBS6657 isolate is similar to the MAGV prototype, whereas 2 of the other MAGV-like isolates are located on a distinct branch and most likely warrant classification as a separate virus species and 1 is, in fact, a misclassified CVV strain. Our findings provide clear evidence that MAGV can cause human disease.


Bulletin of The World Health Organization | 2016

Measuring Haitian children's exposure to chikungunya, dengue and malaria

Mathieu J. P. Poirier; Delynn M. Moss; Karla R. Feeser; Thomas G. Streit; Gwong-Jen J. Chang; Matthew T. Whitney; Brandy J. Russell; Barbara W. Johnson; Alison J. Basile; Christin H. Goodman; Amanda K. Barry; Patrick J. Lammie

Abstract Objective To differentiate exposure to the newly introduced chikungunya virus from exposure to endemic dengue virus and other pathogens in Haiti. Methods We used a multiplex bead assay to detect immunoglobulin G (IgG) responses to a recombinant chikungunya virus antigen, two dengue virus-like particles and three recombinant Plasmodium falciparum antigens. Most (217) of the blood samples investigated were collected longitudinally, from each of 61 children, between 2011 and 2014 but another 127 were collected from a cross-sectional sample of children in 2014. Findings Of the samples from the longitudinal cohort, none of the 153 collected between 2011 and 2013 but 78.7% (48/61) of those collected in 2014 were positive for IgG responses to the chikungunya virus antigen. In the cross-sectional sample, such responses were detected in 96 (75.6%) of the children and occurred at similar prevalence across all age groups. In the same sample, responses to malarial antigen were only detected in eight children (6.3%) but the prevalence of IgG responses to dengue virus antigens was 60.6% (77/127) overall and increased steadily with age. Spatial analysis indicated that the prevalence of IgG responses to the chikungunya virus and one of the dengue virus-like particles decreased as the sampling site moved away from the city of Léogâne and towards the ocean. Conclusion Serological evidence indicates that there had been a rapid and intense dissemination of chikungunya virus in Haiti. The multiplex bead assay appears to be an appropriate serological platform to monitor the seroprevalence of multiple pathogens simultaneously.

Collaboration


Dive into the Brandy J. Russell's collaboration.

Top Co-Authors

Avatar

Barbara W. Johnson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Christin H. Goodman

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Alison J. Basile

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Aaron C. Brault

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Aridth Gibbons

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Bobbie R. Erickson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Brian R. Amman

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Dianna M. Blau

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jason O. Velez

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jessica A. Belser

National Center for Immunization and Respiratory Diseases

View shared research outputs
Researchain Logo
Decentralizing Knowledge